Effect of a low-dose oral contraceptive containing 20 μg ethinylestradiol and 150 μg desogestrel on dysmenorrhea

Contraception

Volumn 68, Issue 3, 2003, Pages 183-188

  Callejo, J ^a   Diaz J ^b   Ruiz, A ^c   Garcia R M ^d  

^a HOSPITAL SANT JOAN DE DÉU   (Spain)

^b CPF Alzira   (Spain)

^c CPF Dos Hermanas   (Spain)

^d Div Programas Planificacion F   (Spain)

Author keywords

Desogestrel; Dysmenorrhea; Low dose; Oral contraceptive

Indexed keywords

ANALGESIC AGENT; DESOGESTREL PLUS ETHINYLESTRADIOL; LOW DOSE ORAL CONTRACEPTIVE; DESOGESTREL; ETHINYLESTRADIOL; ORAL CONTRACEPTIVE AGENT;

ADULT; ANOREXIA; ARTICLE; ASTHENIA; BACKACHE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIARRHEA; DIZZINESS; DRUG EFFICACY; DYSMENORRHEA; DYSPEPSIA; DYSPHONIA; EPISTAXIS; FEMALE; HEADACHE; HIRSUTISM; HUMAN; LIBIDO DISORDER; LOW BACK PAIN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MENTAL INSTABILITY; NAUSEA; NERVOUSNESS; ORAL CONTRACEPTION; PAIN ASSESSMENT; SCORING SYSTEM; SPOTTING; VISUAL ANALOG SCALE; ADOLESCENT; MULTICENTER STUDY; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; ANALGESICS; CONTRACEPTIVES, ORAL; DESOGESTREL; DYSMENORRHEA; ETHINYL ESTRADIOL; FEMALE; HUMANS; PAIN MEASUREMENT; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 1642337920     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(03)00132-X     Document Type: Article

References (11)

1. Coco A.S. Primary dysmenorrhea. Am Fam Physician. 60:1999;489-496.
2. Davis A.R., Westhoff C.L. Primary dysmenorrhea in adolescent girls and treatment with oral contraceptives. J Pediatr Adolesc Gynecol. 14:2001;3-8.
3. Dawood M.Y. Current concepts in the etiology and treatment of primary dysmenorrhea. Acta Obstet Gynecol Scand Suppl. 138:1986;7-10.
4. Courtland Robinson J., Plichta S., Weisman C.S., et al. Dysmenorrhea and use of oral contraceptives in adolescent women attending a family planning clinic. Am J Obstet Gynecol. 166:1992;578-583.
5. Sundell G., Milsom I., Andersch B. Factors influencing the prevalence and severity of dysmenorrhoea in young women. Br J Obstet Gynaecol. 97:1990;588-594.
6. Milsom I., Andersch B. Effects of various oral contraceptive combinations on dysmenorrhea. Gynecol Obstet Invest. 17:1984;284-292.
7. Vree ML. Effect on dysmenorrhea and cycle control following the use of a low-dose desogestrel-containing pill. Eur J Contracept Reprod Health Care 2000;5(Suppl 1):72(P1-33).
8. Serfaty D., Vree M.L. A comparison of the cycle control and tolerability of two ultra low-dose oral contraceptives containing 20 μg ethinylestradiol and either 150 μg desogestrel or 75 μg gestodene. Eur J Contracept Reprod Health Care. 3:1998;179-189.
9. Littman G.S., Walker B.R., Schneider B.E. Reassessment of verbal and visual analog ratings in analgesic studies. Clin Pharmacol Ther. 38:1985;16-23.
10. Egarter C., Topcuoglu M.A., Imhof M., Huber J. Low dose oral contraceptives and quality of life. Contraception. 59:1999;287-291.
11. Ernst U., Baumgartner L., Janssen G. Improvement of quality of life in women using a low-dose desogestrel-containing contraceptive results of an observational clinical evaluation. Eur J Contracept Reprod Health Care. 7:2002;238-243.